Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Westervelt

Showing results (321-330 of 359) with videos related to

Pageof 36
Sort By:
Transplantation and Cellular Therapy|January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trialJoseph Pidala, Brent Logan, Stephanie J Lee, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional TrialJason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Blood|October 24, 2015
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemiaJane E Churpek, Khateriaa Pyrtel, Krishna-Latha Kanchi, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Eclinicalmedicine|May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
The New England Journal of Medicine|October 19, 2012
Peripheral-blood stem cells versus bone marrow from unrelated donorsClaudio Anasetti, Brent R Logan, Stephanie J Lee, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Pageof 36

Showing results (321-330 of 359) with videos related to

Sort By:
Pageof 36
Transplantation and Cellular Therapy|January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trialJoseph Pidala, Brent Logan, Stephanie J Lee, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional TrialJason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Blood|October 24, 2015
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemiaJane E Churpek, Khateriaa Pyrtel, Krishna-Latha Kanchi, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Eclinicalmedicine|May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
The New England Journal of Medicine|October 19, 2012
Peripheral-blood stem cells versus bone marrow from unrelated donorsClaudio Anasetti, Brent R Logan, Stephanie J Lee, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Pageof 36